<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01083446</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-08-NV-236</org_study_id>
    <secondary_id>0236-08-TLV</secondary_id>
    <nct_id>NCT01083446</nct_id>
  </id_info>
  <brief_title>A Nutritional Approach to Minimal Hepatic Encephalopathy</brief_title>
  <official_title>A Nutritional Approach to Minimal Hepatic Encephalopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will study a possible effect of standard Israeli breakfast (30% of caloric value
      and 21 gram protein) on cognitive and executive functions (working memory, visual memory,
      concentration and coordination), on patients with mild-moderate liver cirrhosis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">August 2010</completion_date>
  <primary_completion_date type="Anticipated">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Minimal Hepatic Encephalopathy</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nutritional intervention, standard Israeli breakfast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nutritional Intervention, fast</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional Intervention</intervention_name>
    <description>Cognitive and executive functions before and after standard israeli breakfast (30% of caloric value and 21 gram protein)</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional Intervention</intervention_name>
    <description>Cognitive and executive functions during fast</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All consented adults (age &gt; 18), with the diagnosis of CHILD A cirrhosis with MELD
             score of &lt; 10.

          -  Diagnosis of liver cirrhosis as documented by liver biopsy (stage IV) and / or
             fibroscan (score &gt; 12 kpa) and / or fibrotest (score &gt; 0.74) and /or imaging.

        Exclusion Criteria:

          -  History of &gt; grade II hepatic encephalopathy (HE).

          -  Diagnosis of dementia, Parkinson disease, Schizophrenia (Patients with major
             depression will be noted but not excluded).

          -  Use of sedatives, tranquilizers or anti- psychotic medication during and/or 2 weeks
             prior to enrolling Use of antibiotics for any length of period during and/or 2 weeks
             prior to enrolling.

          -  Current use of lactulose or neomycin.

          -  Use of alcohol or elicit drugs during and/ or 6 months prior to enrolling.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nachum Vaisman, Prof'</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel-Aviv Sourasky Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nachum Vaisman, Prof'</last_name>
    <phone>+972-3-6974807</phone>
    <email>vaisman@tasmc.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nachum Vaisman, Prof'</last_name>
      <phone>+972-3-6974807</phone>
      <email>vaisman@tasmc.health.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2008</study_first_submitted>
  <study_first_submitted_qc>March 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2010</study_first_posted>
  <last_update_submitted>March 8, 2010</last_update_submitted>
  <last_update_submitted_qc>March 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Prof' Nachum Vaisman</name_title>
    <organization>Tel-Aviv Sourasky Medical Center</organization>
  </responsible_party>
  <keyword>Encephalopathy</keyword>
  <keyword>Cirrhotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Hepatic Encephalopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

